ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

PPBT Purple Biotech Ltd

0,60
0,03685 (6,54%)
22 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Purple Biotech Ltd PPBT NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
0,03685 6,54% 0,60 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,583 0,53 0,62 0,60 0,56315
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
21.5.202413:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21.5.202413:30GLOBEPurple Biotech Reports First Quarter 2024 Financial Results
25.4.202413:00GLOBEPurple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer..
28.3.202412:00GLOBEPurple Biotech to Present New Data On its Oncology Drug..
14.3.202412:30GLOBEPurple Biotech Reports Preclinical Proof of Concept for its..
06.3.202422:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05.3.202422:00EDGAR2Form 20-F - Annual and transition report of foreign private..
05.3.202413:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05.3.202413:55GLOBEPurple Biotech Reports Fourth Quarter and Full-Year 2023..
27.2.202413:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27.2.202413:00GLOBEPurple Biotech Presents Data of its Phase 1 Head & Neck..
13.2.202413:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13.2.202413:00GLOBEPurple Biotech Convenes a Head & Neck Cancer Scientific..
01.2.202413:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01.2.202413:30GLOBEPurple Biotech Reaches Recommended Phase 2 Dose for NT219
26.1.202422:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20.12.202314:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20.12.202314:05GLOBEPurple Biotech Appoints Dr. Yael Margolin to its Board of..
14.12.202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14.12.202312:50GLOBEPurple Biotech Completes Patient Enrollment in Phase 2..
21.11.202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21.11.202312:50GLOBEPurple Biotech Reports Third Quarter 2023 Financial Results
15.11.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
14.11.202322:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13.11.202322:11EDGAR2Form F-1/A - Registration statement for certain foreign..
02.11.202312:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02.11.202312:00GLOBEPurple Biotech Fortifies NT219 Patent Protection
30.10.202321:30EDGAR2Form F-1 - Registration statement for certain foreign..
19.10.202322:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19.10.202322:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19.10.202321:55GLOBEPurple Biotech Announces Closing of $5 Million Registered..
19.10.202316:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19.10.202316:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17.10.202314:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17.10.202314:00GLOBEPurple Biotech Announces $5 Million Registered Direct..
17.10.202313:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13.10.202313:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06.10.202314:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06.10.202313:50GLOBEPurple Biotech Reports Potential Biomarker Data Support..
03.10.202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03.10.202313:50GLOBEPurple Biotech Reports Positive Interim and Preliminary..
21.9.202314:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21.9.202314:00GLOBEPurple Biotech to Present New CM24 Pancreatic Cancer..
13.9.202314:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22.8.202315:29GLOBEPurple Biotech Reports Second Quarter 2023 Financial Results
22.8.202314:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11.7.202314:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11.7.202314:15GLOBEPurple Biotech Reports Positive Results of CM24 Dose..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock